Showing 1-10 of 3009 results for "".

• Spirituality and Spiritual Care of People With Chronic Neurologic Illness

  https://practicalneurology.com/diseases-diagnoses/alzheimer-disease-dementias/spirituality-and-spiritual-care-of-people-with-chronic-neurologic-illness/35444/
  Despite the spiritual challenges of living with neurologic illness, interventions are available to help ameliorate distress related to existential issues, self-image concerns, conception of personal identity, interpersonal relationships, and grief.
  • Text

• Understanding Dystonia: A Practical Approach to Diagnosis and Management

  https://practicalneurology.com/diseases-diagnoses/movement-disorders/understanding-dystonia-a-practical-approach-to-diagnosis-and-management/49157/
  Clinical history helps corroborate the diagnosis of dystonia and provides clues to its etiology; however, the diagnosis rests on clinical examination, because no gold standard laboratory or imaging tests are available. 
  • Text

• Fluid Biomarkers in Multiple Sclerosis

  https://practicalneurology.com/diseases-diagnoses/ms-immune-disorders/fluid-biomarkers-in-multiple-sclerosis/36255/
  Fluid biomarkers may allow for improvement in diagnosis, prognostication, and monitoring of disease activity and treatment response in multiple sclerosis while reducing reliance on imaging. 
  • Text
• Jonathan E. Howard, MD
  https://practicalneurology.com/profiles/jonathan-e-howard-md/OBByzY/

• Advancing Treat-to-Target Care in Generalized Myasthenia Gravis: Earlier Diagnosis, Standardized Assessment, and Precision Use of FcRn-Directed Therapy

  https://practicalneurology.com/live-events/advancing-treat-to-target-care-in-generalized-myasthenia-gravis-earlier-diagnosis-standardized-assessment-and-precision-use-of-fcrn-directed-therapy/56670/
  Through live expert discussion, examine gMG diagnosis, standardized assessment, treat-to-target care, and the integration of FcRn-directed therapy.
  Location: Phoenix, Arizona, United States
  Date: November 5, 2026; 06:30 PM - 08:30 PM MST
  • Broadcast

• Advancing Treat-to-Target Care in Generalized Myasthenia Gravis: Earlier Diagnosis, Standardized Assessment, and Precision Use of FcRn-Directed Therapy

  https://practicalneurology.com/live-events/advancing-treat-to-target-care-in-generalized-myasthenia-gravis-earlier-diagnosis-standardized-assessment-and-precision-use-of-fcrn-directed-therapy/56673/
  Through live expert discussion, examine gMG diagnosis, standardized assessment, treat-to-target care, and the integration of FcRn-directed therapy.
  Location: Austin, Texas, United States
  Date: October 22, 2026; 06:30 PM - 08:30 PM CT
  • Broadcast

• Advancing Treat-to-Target Care in Generalized Myasthenia Gravis: Earlier Diagnosis, Standardized Assessment, and Precision Use of FcRn-Directed Therapy

  https://practicalneurology.com/live-events/advancing-treat-to-target-care-in-generalized-myasthenia-gravis-earlier-diagnosis-standardized-assessment-and-precision-use-of-fcrn-directed-therapy/56671/
  Through live expert discussion, examine gMG diagnosis, standardized assessment, treat-to-target care, and the integration of FcRn-directed therapy.
  Location: Houston, Texas, United States
  Date: October 23, 2026; 06:30 PM - 08:30 PM CT
  • Broadcast

• Advancing Treat-to-Target Care in Generalized Myasthenia Gravis: Earlier Diagnosis, Standardized Assessment, and Precision Use of FcRn-Directed Therapy

  https://practicalneurology.com/live-events/advancing-treat-to-target-care-in-generalized-myasthenia-gravis-earlier-diagnosis-standardized-assessment-and-precision-use-of-fcrn-directed-therapy/56565/
  Through live expert discussion, examine gMG diagnosis, standardized assessment, treat-to-target care, and the integration of FcRn-directed therapy.
  Location: Palo Alto, California, United States
  Date: October 20, 2026; 06:30 PM - 08:30 PM PT
  • Broadcast
• Barancik Prize Awarded to Sergio E. Baranzini, PhD at ACTRIMS 2024
  https://practicalneurology.com/news/barancik-prize-awarded-to-sergio-e-baranzini-phd-at-actrims-2024/2470413/
  This year, the National Multiple Sclerosis Society has awarded Sergio E. Baranzini, PhD the prestigious Barancik Prize for Innovation in Multiple Sclerosis (MS) Research. Professor Baranzini is a geneticist, neuroimmunologist, and data scientist at the University of California, San Francisco (UCS
• Award Recipients Recognized at 2025 International MDS Conference
  https://practicalneurology.com/news/award-recipients-recognized-at-the-2025-international-congress-of-parkinsons-disease-and-movement-disorders/2483939/
  The International Parkinson’s Disease and Movement Disorders Society (MDS) has recognized recipients of the 2025 MDS Awards. The awards honor professionals in the field who are elevating care for movement disorders through their contributions to research, scholarship, and clinical work. The award

• Prev
• 1
• 2
• 3
• …
• 300
• 301
• Next